Clinical trial
Prophylaxis of Psychiatric Symptoms During Anti-HCV Treatment
NCT00133276 · Foundation for Liver Research, Other · Completed
Key facts
| NCT number | NCT00133276 |
|---|---|
| Title | Prophylaxis of Psychiatric Symptoms During Anti-HCV Treatment |
| Official title | Prophylactic Treatment of Peginterferon-associated Psychopathology. A Double-blind Placebo-controlled Trial on the Effects of Escitalopram (Lexapro®) in Patients Treated With Peginterferon and Ribavirin (POPS Study) |
| Lead sponsor | Foundation for Liver Research, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis C |
| Intervention type | Drug, Other |
| Interventions | Escitalopram, Placebo |
| Enrollment | 80 |
| Start date | Aug 1, 2005 |
| Primary completion | Jun 1, 2008 |
| Completion | Dec 1, 2009 |
| First posted | Aug 23, 2005 |
| Last update posted | Feb 19, 2010 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: